TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. April 21, 2006
TCL Archive DePinho Seeks Broad Waiver From COI Policy To Cover Financial Ties With 12 Entities September 21, 2012
TCL Archive FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity? August 15, 1997
TCL Archive NCI Adds New Wrinkle To Drug Distribution Plan – Individual Investigators To Work Through Centers March 25, 1977
TCL Archive Shortage Of Patients In Right Place, Time Develops As Major Problem For Investigators May 3, 1974
